These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 21308986

  • 1. An in vitro study of blood compatibility of vascular grafts made of bacterial cellulose in comparison with conventionally-used graft materials.
    Fink H, Hong J, Drotz K, Risberg B, Sanchez J, Sellborn A.
    J Biomed Mater Res A; 2011 Apr; 97(1):52-8. PubMed ID: 21308986
    [Abstract] [Full Text] [Related]

  • 2. Real-time measurements of coagulation on bacterial cellulose and conventional vascular graft materials.
    Fink H, Faxälv L, Molnár GF, Drotz K, Risberg B, Lindahl TL, Sellborn A.
    Acta Biomater; 2010 Mar; 6(3):1125-30. PubMed ID: 19800035
    [Abstract] [Full Text] [Related]

  • 3. Improved blood compatibility of a stent graft by combining heparin coating and abciximab.
    Christensen K, Larsson R, Emanuelsson H, Elgue G, Larsson A.
    Thromb Res; 2005 Mar; 115(3):245-53. PubMed ID: 15617748
    [Abstract] [Full Text] [Related]

  • 4. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
    Christensen K, Larsson R, Emanuelsson H, Elgue G, Larsson A.
    Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
    [Abstract] [Full Text] [Related]

  • 5. Hemocompatibility study of a bacterial cellulose/polyvinyl alcohol nanocomposite.
    Leitão AF, Gupta S, Silva JP, Reviakine I, Gama M.
    Colloids Surf B Biointerfaces; 2013 Nov 01; 111():493-502. PubMed ID: 23880088
    [Abstract] [Full Text] [Related]

  • 6. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
    Heyligers JM, Lisman T, Verhagen HJ, Weeterings C, de Groot PG, Moll FL.
    J Vasc Surg; 2008 Feb 01; 47(2):324-9; discussion 329. PubMed ID: 18241756
    [Abstract] [Full Text] [Related]

  • 7. In vitro hemo- and cytocompatibility of bacterial nanocelluose small diameter vascular grafts: Impact of fabrication and surface characteristics.
    Wacker M, Kießwetter V, Slottosch I, Awad G, Paunel-Görgülü A, Varghese S, Klopfleisch M, Kupitz D, Klemm D, Nietzsche S, Petzold-Welcke K, Kramer F, Wippermann J, Veluswamy P, Scherner M.
    PLoS One; 2020 Feb 01; 15(6):e0235168. PubMed ID: 32579611
    [Abstract] [Full Text] [Related]

  • 8. Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
    Moll S, De Moerloose P, Reber G, Schifferli J, Leski M.
    Int J Artif Organs; 1990 May 01; 13(5):273-9. PubMed ID: 2142140
    [Abstract] [Full Text] [Related]

  • 9. In vitro haemocompatibility of a novel bioprosthetic total artificial heart.
    Jansen P, van Oeveren W, Capel A, Carpentier A.
    Eur J Cardiothorac Surg; 2012 Jun 01; 41(6):e166-72. PubMed ID: 22491668
    [Abstract] [Full Text] [Related]

  • 10. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
    Heyligers JM, Verhagen HJ, Rotmans JI, Weeterings C, de Groot PG, Moll FL, Lisman T.
    J Vasc Surg; 2006 Mar 01; 43(3):587-91. PubMed ID: 16520178
    [Abstract] [Full Text] [Related]

  • 11. Coagulation and complement activation.
    Christensen K, Larsson R, Emanuelsson H, Elgue G, Larsson A.
    Biomaterials; 2001 Feb 01; 22(4):349-55. PubMed ID: 11205438
    [Abstract] [Full Text] [Related]

  • 12. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
    Lin PH, Chen C, Bush RL, Yao Q, Lumsden AB, Hanson SR.
    J Vasc Surg; 2004 Jun 01; 39(6):1322-8. PubMed ID: 15192575
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
    Lin PH, Bush RL, Yao Q, Lumsden AB, Chen C.
    J Surg Res; 2004 May 01; 118(1):45-52. PubMed ID: 15093716
    [Abstract] [Full Text] [Related]

  • 14. The effect of heparin vs. citrate on the interaction of platelets with vascular graft materials.
    Kottke-Marchant K, Anderson JM, Rabinovitch A, Huskey RA, Herzig R.
    Thromb Haemost; 1985 Dec 17; 54(4):842-8. PubMed ID: 2935968
    [Abstract] [Full Text] [Related]

  • 15. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J, Xue L, Husak VA, Ellinger J, Singh G, Zamora PO, Greisler HP.
    J Vasc Surg; 2004 May 17; 39(5):1059-65. PubMed ID: 15111862
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface.
    Larsson R, Elgue G, Larsson A, Ekdahl KN, Nilsson UR, Nilsson B.
    Immunopharmacology; 1997 Dec 17; 38(1-2):119-27. PubMed ID: 9476123
    [Abstract] [Full Text] [Related]

  • 17. Hirudin versus heparin for use in whole blood in vitro biocompatibility models.
    Bexborn F, Engberg AE, Sandholm K, Mollnes TE, Hong J, Nilsson Ekdahl K.
    J Biomed Mater Res A; 2009 Jun 15; 89(4):951-9. PubMed ID: 18470919
    [Abstract] [Full Text] [Related]

  • 18. The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation.
    Gabutti L, Ferrari N, Mombelli G, Keller F, Marone C.
    J Nephrol; 2004 Jun 15; 17(6):819-25. PubMed ID: 15593057
    [Abstract] [Full Text] [Related]

  • 19. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response.
    Lamba NM, Courtney JM, Gaylor JD, Lowe GD.
    Biomaterials; 2000 Jan 15; 21(1):89-96. PubMed ID: 10619682
    [Abstract] [Full Text] [Related]

  • 20. A protamine filter for extracorporeal heparin removal. Development, testing, blood compatibility evaluation, and future direction.
    Byun Y, Yun JH, Han IS, Fu Y, Shanberge JN, Yang VC.
    ASAIO J; 1995 Jan 15; 41(3):M301-5. PubMed ID: 8573812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.